Friday, April 26th from 10:30 AM - 12:00 PM, Room AD11

Chairs                 

Dr Matthew Chico, Associate Professor, London School of Hygiene & Tropical 

Dr Hellen Barsosio, Assistant Principal Clinical Research Scientist, Kenya Medical Research Institute, Kisumu, Kenya

Liverpool School of Tropical Medicine, Liverpool, United Kingdom

Presentations

Effect of community delivery of IPTp-SP on coverage in Democratic Republic of Congo, Nigeria, Madagascar and Mozambique

Dr Raquel González (ISGlobal)

More than just an antimalarial?: The case for SP for IPTp

Dr Michelle Roh (University of California San Francisco)

Effects of metronidazole plus intermittent preventive treatment of malaria in pregnancy: a double blinded randomised, partly placebo-controlled trial among women in Zambia without HIV (ASPIRE trial)

Dr Mike Chaponda (Tropical Disease Research Centre)

Serial detection of chlamydia, gonorrhoea, trichomoniasis infections by PCR among women given intermittent preventive treatment of malaria in pregnancy (ASPIRE trial)

Dr Patricia Hunter (University of College London)

Safety and efficacy of dihydroartemisinin-piperaquine for IPTp in HIV-infected pregnant women from Gabon and Mozambique

Dr Tacilta Nhampossa (Manhiça Health Research Center)

Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily cotrimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial

(IMPROVE-2 trial)

Dr Hellen Barsosio (Kenya Medical Research Institute and Liverpool School of Tropical Medicine)